이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

비만 및/또는 심혈관 대사 위험이 높은 과체중 환자의 치료를 위한 영양실조의 효능 (TOOLBAR)

2026년 9월 25일 업데이트: Assistance Publique - Hôpitaux de Paris

비만 및/또는 심혈관 대사 위험이 높은 과체중 환자 치료를 위한 영양실조(OBE-COACH)의 효능

The OBE-COACH program is an automated online nutritional coaching service that was evaluated in its first version (MXS-CARE program) in a clinical trial coordinated by our team, in type 2 diabetic patients with abdominal obesity. Results have confirmed the efficiency of the program to improve lifestyle habits, including the 4-month diet, and to reduce weight and HbA1c levels.

Based on our experience and the scientific literature, the investigators assume that adherence to the program may diminish in the long term to the point of calling into question its efficiency. So IRIADE compagny developed an enhanced program called OBE-COACH. The OBE-COACH program has been specifically designed to facilitate long-term user adherence. The OBE-COACH program, integrates a bidirectional interactive link between the patient and an automated support system (IRIADE-MED system) associated with an inexpensive remote human support.

In the TOOLBAR study, the investigators will evaluate the efficiency of the OBE-COACH solution in a population of obese patients or overweight persons with at least one cardiometabolic risk factor.

A group of patients will have access to the OBE-COACH program. It will be compared to a control group which will receive an e-learning program with free access to advice sheets via the web, to a menu generator, videos and a catalog of physical activity, (resources made available by the web site www.mangerbouger.fr (public health France, ministry in charge of health) . Indeed, the investigators judged that the loss of patients during follow-up would be greater if e-learning was not offered in the control group.

연구 개요

상세 설명

The management of patients in the TOOLBAR study will be in accordance with French recommendations: a patient who is overweight should benefit from a dietary, physical activity, psychological assistance and medical monitoring advices which can be provided by a general practitioner. In the control group, subjects have access to an e-learning program, including free access via the web to a nutritional information portal and to automated tools providing information and advice for adopting a balanced, low-carb diet and to practice physical activity in line with the guidelines of the national health nutrition plan (PNNS). However, this group will not have access to the OBE-COACH program. The usual follow-up with the attending doctor will be continued.

Patients will be assessed at baseline, 6 months and 12 months. In an ancillary study they could be also assessed at 24 months.

연구 유형

중재적

등록 (실제)

346

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Paris, 프랑스, 75013
        • Hôpital La Pitié Salpêtrière

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Men or women 18 to 75 years
  • Obesity defined by a body mass index > 30 kg / m2 or a BMI> 25 kg / m2 with the presence of at least one major cardiometabolic risk factors among the followings: dyslipidemia, hypertension, diabetes, prediabetes
  • Stable weight in the last six months (weight variation < 4 kg peak-to-peak)
  • Access and current use of internet, possession of an email address and a smartphone.
  • Understanding and reading French
  • Patient not currently following a nutritional monitoring and not having planned to be engaged in a nutritional monitoring during the coming year

Exclusion Criteria:

  • Excessive alcohol consumption > 30 g / day -Pregnant or breastfeeding woman
  • symptomatic cardiovascular disease : angina, lower extremity arterial occlusive disease, stroke or myocardial infarction dating of less than 6 months.
  • Uncontrolled psychiatric illness
  • Patients receiving or about to receive during the study period a systemic or local treatment susceptible to interfere with the evaluation of the primary criteria (corticosteroids, antipsychotics, tricyclic antidepressants) except if these treatments have been stable for at least 6 months without a plan to modify the dose during the 12 months of the study
  • Adhering to a prescribed diet for weight loss, in the past 3 months
  • Person with a severe eating disorder: bulimia, binge eating disorder according to DSM-V criteria - Presence of celiac disease, Crohn's disease or other metabolic disorder or condition affecting nutritional needs such as allergies or food intolerances (except partial lactose intolerance)
  • Anticipated difficulties in following the patient
  • Lack of social coverage in France
  • Lack of written or electronic informed consent

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 지지 요법
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: OBE-COACH program

The OBE-COACH experimental group: access to the complete OBE-COACH program

OBE-COACH works through private exchanges between the user and an automatic generator of recommendations, advice and messages of encouragement. Web focus groups are propoposed by specialist to respond to the questions of the participants and a tele-interview at 6 months with a dietetician to encourage and assist the patient to make the best use of the program.

The program is divided into missions to perform. These missions are grouped into 10 families. The completion of each mission and the correct answers to the quiz offer points and bonuses.

To promote better adherence to the program, missions are not repetitive. They are proposed to surprise the user and constantly renew his desire to connect to the program and achieve goals.

The intensity level of the program is selected by the user at any time.

Connected devices provide to patient are auto-tensiometer and balance. These devices will not be connected to the OBE-COACH program.

The auto-tensiometer (Tensio-screen, Terraillon) is a connected tensiometer allowing the patient to measure by himself with an armband his systolic and diastolic blood pressure and his heart rate.

The balance (Web coach premium, Terraillon) is a connected scale to collect body weight.

The Activity Tracer (activi-T band, Terraillon) is a a wristband connected activity tracer worn on the wrist that tracks the patient's physical activity and calculates the number of steps, distance traveled and calories burned. The Activity Tracer will not be connected to the OBE-COACH program.

활성 비교기: e-learning program

The control group: access to an e-learning program with free access via the web to advice sheets, a menu generator and a catalog of physical activity (resources made available by the site www.mangerbouger.fr ; Public Health France, Ministry of Health) and provision of connected devices (auto-tensiometer and balance).

Connected devices provide to patient are auto-tensiometer and balance. These devices will not be connected to the OBE-COACH program.

The auto-tensiometer (Tensio-screen, Terraillon) is a connected tensiometer allowing the patient to measure by himself with an armband his systolic and diastolic blood pressure and his heart rate.

The balance (Web coach premium, Terraillon) is a connected scale to collect body weight.

The Activity Tracer (activi-T band, Terraillon) is a a wristband connected activity tracer worn on the wrist that tracks the patient's physical activity and calculates the number of steps, distance traveled and calories burned. The Activity Tracer will not be connected to the OBE-COACH program.

e-learning program with free access via the web to advice sheets, a menu generator and a catalog of physical activity (resources made available by the site www.mangerbouger.fr ; Public Health France, Ministry of Health)

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Weight reduction of at least 5% between 0 and 12 months.
기간: 12 months

Weight reduction of at least 5% between 0 and 12 months. The weight, in Kg, will be measured in a state of fastness ≥ 8h, in participants wearing light clothing without shoes on the same scales calibrated at inclusion and 12 months of follow-up.

12 months

2차 결과 측정

결과 측정
측정값 설명
기간
검증된 NAQA 설문지로 평가한 0~12개월 간의 단백질 섭취량 변화(g/일)
기간: 12 개월
12 개월
검증된 NAQA 설문지로 평가된 0~12개월 사이의 자당 섭취량(g/일) 변화
기간: 12 개월
12 개월
검증된 NAQA 설문지로 평가한 0~12개월 간의 지질 섭취량(g/day) 변화
기간: 12 개월
12 개월
검증된 NAQA 설문지로 평가된 0~12개월 간의 칼슘 섭취량(mg/일) 변화
기간: 12 개월
12 개월
0~12개월 사이의 가당 음료 섭취량(잔/일) 변화
기간: 12 개월
12 개월
0~12개월 사이의 알코올 음료 소비량(잔/일) 변화
기간: 12 개월
12 개월
0~6개월 사이의 가당 음료 섭취량(잔/일) 변화
기간: 6 개월
6 개월
0~6개월 사이의 알코올 음료 소비량 변화(잔/일)
기간: 6 개월
6 개월
0~12개월 간의 담배 소비량 변화(담배/일)
기간: 12 개월
12 개월
0~6개월 간의 담배 소비량 변화(담배/일)
기간: 6 개월
6 개월
GPAQ 설문지로 평가된 과업의 대사 동등성(MET)에서 측정된 신체 활동에 대한 WHO 권장 사항 준수의 0~12개월 사이의 변화.
기간: 12 개월
12 개월
GPAQ 설문지로 평가한 과업의 대사 동등성(Metabolic Equivalent of Task, MET)에서 측정한 신체 활동에 대한 WHO 권장 사항 준수의 0~6개월 사이의 변화.
기간: 6 개월
6 개월
12개월 동안 OBE-COACH 프로그램 준수, 지난 달 동안 주당 피험자의 답변이 포함된 질문(IRIADE에서 보낸)의 평균 비율로 평가됨.
기간: 12 개월
12 개월
지난 6개월 동안 웹 포커스 그룹에 참여한 횟수로 평가된 12개월의 OBE-COACH 프로그램 준수.
기간: 12 개월
12 개월
6개월 동안 OBE-COACH 프로그램 준수, 전월 동안 주당 피험자의 답변이 포함된 질문(IRIADE에서 보낸)의 평균 비율로 평가됨.
기간: 6 개월
6 개월
지난 6개월 동안 웹 포커스 그룹에 참여한 수로 평가된 6개월의 OBE-COACH 프로그램 준수.
기간: 6 개월
6 개월
TFEQ21 설문지로 평가된 음식 충동성의 0~12개월 사이의 변화
기간: 12 개월
12 개월
TFEQ21 설문지로 평가한 음식 충동성의 0~6개월 사이의 변화
기간: 6 개월
6 개월
HAD 설문지(점수 0~21)로 측정한 불안 증상의 0~12개월 사이의 변화
기간: 12 개월
12 개월
Weight reduction of at least 5% between 0 and 6 months.
기간: 6 months

Weight, in Kg, measured in the same conditon at baseline and 6 months.

6 months
Weight change between 0 and 6 months
기간: 6 months

Weight, in Kg, measured in the same conditon at baseline and 6 months.

6 months
Weight change between 0 and 12 months
기간: 12 months

Weight, in Kg, measured in the same conditon at baseline and 12 months.

12 months
Waist change between 0 and 6 months
기간: 6 months

Waist, in cm, measured midway between the last ribs and the anterior superior iliac crest

6 months
Waist change between 0 and 12 months
기간: 12 months

Waist, in cm, measured midway between the last ribs and the anterior superior iliac crest

12 months
Triglycerids change between 0 and 12 months
기간: 12 months

Plasma fasting levels of triglycerides in g/L

12 months
HDL cholesterol change between 0 and 12 months
기간: 12 months

Plasma fasting levels of HDL cholesterol in g/L

12 months
LDL cholesterol change between 0 and 12 months
기간: 12 months

Plasma fasting levels of LDL cholesterol in g/L

12 months
non-HDL cholesterol change between 0 and 12 months
기간: 12 months

Plasma fasting levels of non-HDL cholesterol in g/L (total cholesterol less HDL-C)

12 months
Blood glucose change between 0 and 12 months
기간: 12 months

Plasma fasting levels of glucose in g/L

12 months
HbA1c change between 0 and 12 months
기간: 12 months

Plasma fasting levels of HbA1c in percentage

12 months
Systolic blood pressure change between 0 and 12 months
기간: 12 months

Systolic blood pressure in mmHg as the average of the last 2 automatic measurements out of 3 taken at the level of one arm and spaced about 2 min in the cabinet or by the patient with the auto-tensiometer

12 months
Diastolic blood pressure change between 0 and 12 months
기간: 12 months

Diastolic blood pressure in mmHg as the average of the last 2 automatic measurements out of 3 taken at the level of one arm and spaced about 2 min in the cabinet or by the patient with the auto-tensiometer

12 months
Triglycerids change between 0 and 6 months
기간: 6 months

Plasma fasting levels of triglycerides in g/L

6 months
HDL cholesterol change between 0 and 6 months
기간: 6 months

Plasma fasting levels of HDL cholesterol in g/L

6 months
LDL cholesterol change between 0 and 6 months
기간: 6 months

Plasma fasting levels of LDL cholesterol in g/L

6 months
non-HDL cholesterol change between 0 and 6 months
기간: 6 months

Plasma fasting levels of non-HDL cholesterol in g/L (total cholesterol less HDL-C)

6 months
Blood glucose change between 0 and 6 months
기간: 6 months

Plasma fasting levels of glucose in g/L

6 months
HbA1c change between 0 and 6 months
기간: 6 months

Plasma fasting levels of HbA1c in percentage

6 months
Systolic blood pressure change between 0 and 6 months
기간: 6 months

Systolic blood pressure in mmHg as the average of the last 2 automatic measurements out of 3 taken at the level of one arm and spaced about 2 min in the cabinet or by the patient with the auto-tensiometer

6 months
Diastolic blood pressure change between 0 and 6 months
기간: 6 months

Diastolic blood pressure in mmHg as the average of the last 2 automatic measurements out of 3 taken at the level of one arm and spaced about 2 min in the cabinet or by the patient with the auto-tensiometer

6 months
Change in adherence to the Mediterranean diet : Score PREDIMED
기간: 12 months

Change between 0 and 12 months of adherence to mediterranean diet,evaluated by the dietetic score PREDIMED (validated checklist of 14 items). Higher scores indicate greater adherence to the diet assigned

12 months
Change in adherence to the Mediterranean diet : fruits and vegetables consumption
기간: 12 months

Change between 0 and 12 months in terms of perrcentage of consumption of fruits and vegetables on the recommended 400 g/day

12 months
Change in adherence to the Mediterranean diet : Score PREDIMED
기간: 6 months

Change between 0 and 6 months of adherence to mediterranean diet,evaluated by the dietetic score PREDIMED (validated checklist of 14 items). Higher scores indicate greater adherence to the diet assigned

6 months
Change in adherence to the Mediterranean diet : fruits and vegetables consumption
기간: 6 months

Change between 0 and 6 months in terms of percentage of consumption of fruits and vegetables on the recommended 400 g/day

6 months
Change between 0 and 12 months of Energy intake
기간: 12 months

Energy intake, in Kcal/day, evaluated with the validated NAQA questionnaire

12 months
Change between 0 and 12 months of cholesterol intake
기간: 12 months

Cholesterol intake, in mg/day, evaluated with the validated NAQA questionnaire

12 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Marylou Para, MD, PhD, Assistance Publique - Hôpitaux de Paris

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2024년 1월 2일

기본 완료 (실제)

2025년 6월 22일

연구 완료 (실제)

2025년 6월 22일

연구 등록 날짜

최초 제출

2021년 6월 18일

QC 기준을 충족하는 최초 제출

2021년 6월 18일

처음 게시됨 (실제)

2021년 6월 28일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 30일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 25일

마지막으로 확인됨

2024년 5월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

Data are available upon reasonable request. The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients.

Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.

IPD 공유 기간

Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor

IPD 공유 액세스 기준

Researchers who provide a methodologically sound proposal

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액
  • ICF

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다